Oriana Ciani addresses the financial pressures that healthcare payers face due to rising costs of innovative therapies ...

For decades, chronic disease management in Medicare has been hampered by a fee-for-service payment system that rewards volume and activity rather than true clinical improvement. This model created ...

CMS has been trying to scale value-based care for decades with mixed results — but the agency’s newly announced ACCESS model could represent a more meaningful step toward aligning payment with ...

Care payment models CMS introduced in 2025 include six new initiatives targeting drug pricing, chronic disease, and specialty care payments.

Whole-person care has become a “practical necessity,” yet payment models reflect an era “built around episodic visits, ...

Innovative financing and reimbursement models can improve access to cell and gene therapies, addressing cost barriers and improving patient outcomes, said Joe DePinto, MBA, of McKesson. Innovative ...

The CMS CGT Access Model involves 33 states, D.C., and Puerto Rico, focusing on sickle cell disease treatments for Medicaid beneficiaries. Outcomes-based contracts with manufacturers ensure discounts ...